Do current oral ciprofloxacin regimens achieve pharmacokinetic/pharmacodynamic targets within safe exposure limits in older adults with Pseudomonas aeruginosa infection? A population pharmacokinetic analysis
Journal of Antimicrobial Chemotherapy · 04.08.2026 · 81 (9)
DOI: 10.1093/jac/dkag283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 14.08.2026. Verfasst von Mehdi El Hassani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montréal, Canada. Hauptthemen laut MEDLINE: Ciprofloxacin, Pseudomonas Infections, Anti-Bacterial Agents, Pseudomonas aeruginosa. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Fonds de Recherche du Québec-Santé, Réseau Québécois de Recherche sur les Médicaments, Canada Foundation for Innovation.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Ciprofloxacin is one of the few orally available antibiotics with activity against Pseudomonas aeruginosa. This study developed a population pharmacokinetic (popPK) model for oral ciprofloxacin in older adults and evaluated whether standard regimens achieve the pharmacokinetic/pharmacodynamic (PK/PD) target of 24 h area under the concentration–time curve over minimal inhibitory concentration (AUC0-24/MIC) ≥ 125.
Methods
This was a prospective pilot study in patients ≥75 years taking oral ciprofloxacin at the McGill University Health Centre, Canada. Plasma samples were collected at steady state (peak, mid-interval, trough) and data fitting was performed using NONMEM with stochastic approximation expectation–maximization. Monte Carlo simulations (n = 1000) assessed the probability of target attainment (PTA) for standard dosing regimens of 250–750 mg q12h across MICs of 0.125–2 mg/L.
Results
Fifteen patients (median age 82 years, weight 75 kg, creatinine clearance 46 mL/min) contributed 42 plasma concentrations to the analysis. A one-compartment model with first-order absorption and elimination best described the data. Population mean apparent clearance and volume of distribution were 14.3 L/h and 247 L, respectively (resulting in a 12 h half-life), with high interindividual variability (IIV: 75.2% and 36.0%). The absorption rate constant was fixed to 2.5 h−1. No covariate effects were retained in the final model. At the P. aeruginosa clinical MIC breakpoint of 0.5 mg/L, standard regimens achieved PTAs of 18.7% (250 mg q12h), 56.6% (500 mg q12h), and 76.5% (750 mg q12h).
Conclusions
This first popPK model for oral ciprofloxacin specifically in older adults demonstrates that simulated standard dosing regimens fail to achieve PK/PD targets for P. aeruginosa. The large IIV, increased drug exposure and low target attainment support implementation of therapeutic drug monitoring in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Université de Montréal, Montréal, Canada.
- Department of Pharmacy, McGill University Health Centre, Montréal, Canada.
- Department of Medicine, McGill University Health Centre, Montréal, Canada.
ORCID-Profile: Daniel J G Thirion, Emily G McDonald
Förderung
- Fonds de Recherche du Québec-Santé
- Réseau Québécois de Recherche sur les Médicaments
- Canada Foundation for Innovation
- CSHP Research and Education Foundation
Zitieren
APA
El Hassani, M., Thirion, D. J. G., Yaliniz, A., Desforges, K., Verdon, J., McDonald, E. G., & Marsot, A. (2026). Do current oral ciprofloxacin regimens achieve pharmacokinetic/pharmacodynamic targets within safe exposure limits in older adults with Pseudomonas aeruginosa infection? A population pharmacokinetic analysis. Journal of Antimicrobial Chemotherapy, 81(9). https://doi.org/10.1093/jac/dkag283
Vancouver
El Hassani M, Thirion DJG, Yaliniz A, Desforges K, Verdon J, McDonald EG, et al. Do current oral ciprofloxacin regimens achieve pharmacokinetic/pharmacodynamic targets within safe exposure limits in older adults with Pseudomonas aeruginosa infection? A population pharmacokinetic analysis. Journal of Antimicrobial Chemotherapy. 2026;81(9). doi:10.1093/jac/dkag283
BibTeX
@article{ElHassani2026,
author = {El Hassani, Mehdi and Thirion, Daniel J G and Yaliniz, Aysenur and Desforges, Katherine and Verdon, Josée and McDonald, Emily G and Marsot, Amélie},
title = {Do current oral ciprofloxacin regimens achieve pharmacokinetic/pharmacodynamic targets within safe exposure limits in older adults with Pseudomonas aeruginosa infection? A population pharmacokinetic analysis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {9},
doi = {10.1093/jac/dkag283}
}
EUVIMED